BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+24.52%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.49T
AUM Growth
+$456B
(+22%)
Cap. Flow
+$33.6B
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
18.95%
Holding
5,148
New
189
Increased
2,433
Reduced
1,897
Closed
168
Top Buys
| 1 |
Amazon
AMZN
|
+$2.47B |
| 2 |
AbbVie
ABBV
|
+$2.16B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.99B |
| 4 |
Otis Worldwide
OTIS
|
+$1.83B |
| 5 |
Carrier Global
CARR
|
+$1.71B |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.76B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| 1 | Technology | 22.08% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 12.21% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Invesco Senior Loan ETF
BKLN
$6.89B
| $42.3M | ﹤0.01% |
1,979,090
-291,477
| -13% | -$6.22M |
|
2327
Codexis
CDXS
$220M
| $42.2M | ﹤0.01% |
3,703,249
+105,274
| +3% | +$1.2M |
|
2328
iShares National Muni Bond ETF
MUB
$39.5B
| $42.1M | ﹤0.01% |
365,165
+7,797
| +2% | +$900K |
|
2329
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.94B
| $42.1M | ﹤0.01% |
1,125,111
+1,124,992
| +945,371% | +$42.1M |
|
2330
Frontline
FRO
$5.34B
| $42M | ﹤0.01% |
6,019,163
+5,722,946
| +1,932% | +$39.9M |
|
|
CAMP
2331
DELISTED
CalAmp Corp.
CAMP
| $42M | ﹤0.01% |
227,813
-10,234
| -4% | -$1.89M |
|
2332
Ennis
EBF
$465M
| $41.9M | ﹤0.01% |
2,311,927
-8,128
| -0.4% | -$147K |
|
2333
Quince Therapeutics
QNCX
$85.9M
| $41.9M | ﹤0.01% |
905,412
+252,691
| +39% | +$11.7M |
|
2334
Sportsman's Warehouse
SPWH
$118M
| $41.9M | ﹤0.01% |
2,940,060
-16,034
| -0.5% | -$228K |
|
2335
Anterix
ATEX
$403M
| $41.9M | ﹤0.01% |
923,465
+156,946
| +20% | +$7.12M |
|
2336
Camden National
CAC
$681M
| $41.9M | ﹤0.01% |
1,212,161
-16,627
| -1% | -$574K |
|
2337
iHeartMedia
IHRT
$429M
| $41.6M | ﹤0.01% |
4,981,838
+2,496,908
| +100% | +$20.8M |
|
2338
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.02B
| $41.6M | ﹤0.01% |
601,084
+579,342
| +2,665% | +$40.1M |
|
|
NVEE
2339
DELISTED
NV5 Global
NVEE
| $41.5M | ﹤0.01% |
3,265,592
+95,248
| +3% | +$1.21M |
|
2340
Evolent Health
EVH
$1,000M
| $41.5M | ﹤0.01% |
5,824,624
+137,247
| +2% | +$977K |
|
2341
Stoneridge
SRI
$230M
| $41.5M | ﹤0.01% |
2,006,986
+5,736
| +0.3% | +$119K |
|
2342
Amneal Pharmaceuticals
AMRX
$3.07B
| $41.3M | ﹤0.01% |
8,686,677
-613,296
| -7% | -$2.92M |
|
2343
Ardelyx
ARDX
$1.57B
| $41.3M | ﹤0.01% |
5,969,802
+779,493
| +15% | +$5.39M |
|
|
RDS.A
2344
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $41.3M | ﹤0.01% |
1,263,325
-29,296
| -2% | -$958K |
|
|
WTRU
2345
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
| $41.3M | ﹤0.01% |
730,101
+292,858
| +67% | +$16.6M |
|
2346
ADT
ADT
$7.19B
| $41.2M | ﹤0.01% |
5,161,429
-1,079,523
| -17% | -$8.61M |
|
|
SRE.PRB
2347
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
| $41.1M | ﹤0.01% |
418,124
-15,627
| -4% | -$1.54M |
|
|
SLCA
2348
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $40.9M | ﹤0.01% |
11,328,014
-34,778
| -0.3% | -$126K |
|
|
SHYF
2349
DELISTED
The Shyft Group
SHYF
| $40.8M | ﹤0.01% |
2,425,259
+46,578
| +2% | +$784K |
|
|
PRVB
2350
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $40.7M | ﹤0.01% |
2,885,617
+2,203,387
| +323% | +$31.1M |
|